2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Descripción general
Resumen del artículo
These guidelines provide recommendations for cardiovascular risk assessment, prevention, and management in cancer patients and survivors. They emphasize a personalized approach to care based on individual risk factors, cancer type, and cancer therapies.
Explícamelo como si tuviera cinco años
Scientists found that for people with cancer, it's important to also take good care of their heart. So, they made rules to help doctors check each person's heart and keep it healthy, depending on their cancer and treatment.
Posibles conflictos de intereses
The task force received financial support from the ESC without any involvement from the healthcare industry.
Limitaciones identificadas
Explicación de la calificación
These guidelines provide an important framework for managing cardiovascular health in cancer patients. The recommendations are generally well-supported by expert consensus, though higher-quality evidence is needed in many areas. No conflicts of interest were identified beyond funding from the ESC.
Conviene saber
Este es el análisis de Starter. Paperzilla Pro verifica cada cita, investiga los antecedentes de los autores y las fuentes de financiación, y utiliza razonamiento avanzado con IA para ofrecer información más exhaustiva.
Explorar Pro →